Unknown

Dataset Information

0

Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.


ABSTRACT: PURPOSE:To analyze the efficacy and outcome predictors of SD-OCT (spectral-domain optical coherence tomography)-driven ranibizumab treatment in patients with choroidal neovascularization due to myopia (mCNV). METHODS:This prospective investigator-initiated study includes 20 patients with treatment-naïve mCNV. Evaluation included best-corrected visual acuity (BCVA), morphological SD-OCT parameters, and treatment frequency. RESULTS:From baseline to month 12, BCVA improved from 58.5 ± 16.9 to 66.1 ± 14.9 letters. Central retinal thickness (CRT) significantly decreased, and qualitative SD-OCT parameters improved. Better baseline visual acuity (VA), lower spherical equivalent, better inner/outer segment line and external limiting membrane integrity showed a significant positive effect on BCVA outcome. Less fluctuation in CRT (worst minus best CRT) indicated better BCVA at 12 months. No serious adverse events occurred. CONCLUSIONS:SD-OCT-guided intravitreal ranibizumab treatment in mCNV was efficient and safe. We determined useful predictive factors in regard to VA outcome after 12 months.

SUBMITTER: Guichard MM 

PROVIDER: S-EPMC7114905 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia.

Guichard Maria-Magdalena MM   Peters Géraldine G   Tuerksever Cengiz C   Pruente Christian C   Hatz Katja K  

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20190806 2


<h4>Purpose</h4>To analyze the efficacy and outcome predictors of SD-OCT (spectral-domain optical coherence tomography)-driven ranibizumab treatment in patients with choroidal neovascularization due to myopia (mCNV).<h4>Methods</h4>This prospective investigator-initiated study includes 20 patients with treatment-naïve mCNV. Evaluation included best-corrected visual acuity (BCVA), morphological SD-OCT parameters, and treatment frequency.<h4>Results</h4>From baseline to month 12, BCVA improved fro  ...[more]

Similar Datasets

| S-EPMC4997256 | biostudies-literature
| S-EPMC5488753 | biostudies-other
| S-EPMC5384118 | biostudies-other
| S-EPMC6292850 | biostudies-other
| S-EPMC7994577 | biostudies-literature
| S-EPMC5493406 | biostudies-literature
| S-EPMC3410690 | biostudies-literature
| S-EPMC6624808 | biostudies-literature
| S-EPMC9330346 | biostudies-literature
| S-EPMC5533470 | biostudies-other